Olivier Decanniere - Profile and Investment Details

Investor Profile

Olivier Decanniere is a Private Equity Firm based in France with a diverse investment portfolio that includes companies such as Arkadin, Ardian, Kudan, Oxxius, Bio7 Group, Innate Pharma, Ikoula, JIT Solaire, Santédiscount, LBC Tank Terminals, Evernex, T2O media, Clip Industrie, Cegos, Baltkom TV SIA, Elee, BestSecretUPTOO, Seri Jakala, Batiweb.com, IT Relation, Sparus Software, TxCell, Keolis, Kapten & Son US, Eloquant, Euro 4x4 Parts, Alsatis SAS, Ariane Systems, Abvent, JeChange, PHS MEMS, Bravofly, SERMA Group, Saaswedo, GLADD, Pharma Omnium, Cytheris, HR Path, Novacap, H3 Pharma, Cyrus Conseil, Groupe Rivalis, Bellrock, Labosud, ulike, Sfam, CLH Group, Piz'wich, Groupe Charlois, Ceva Santé Animale, Ivalua, Argon & Co, Bricoprivé.com, Streamezzo, Alvest, Unither Pharmaceuticals, Enovos, Wintics, Agendia, AXA Investment Managers, Brainsonic, Place des Leads SAS, Neotys, FiloBlu, Micropross, Angus Chemical, MKD, Sarbacane, erytech, MediFox GmbH, EWE AG, Spie Batignolles SA, S&H Groupe, Ticket Surf International, KOS Group, Fitnessboutique, Chal-Tec GmbH, Clever Age, Autovia Padana, CLS Groupe, Optimind, SPMR, YETI Group, Saal, INDOM, Nutripack Group, Infrastrutture Wireless Italiane, Hawk by TabMo, ProduceShop, Kapten & Son, IWD Retail Software, . Over time, Olivier Decanniere has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Olivier Decanniere is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, E-commerce, Enterprise Software, Network Hardware, Chemical, Artificial Intelligence (AI), Retail, Mobile, Architecture, Software, Manufacturing, Biotechnology, Fashion, FinTech, Jewelry, Consulting, Marketing, Furniture, Developer Tools, Medical, Real Estate, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Olivier Decanniere, as their portfolio suggests a familiarity and interest in this area.

Understanding Olivier Decanniere’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.